What is BioNTech SE (BNTX) stock price today?

BioNTech SE (BNTX) currently trades at $101.57 per share. The stock has a market capitalization of $25.69B and a P/E ratio of —x.

Is BNTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, BioNTech SE has a Smart Value Score of 32/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is 5.82.

What is BioNTech SE's revenue and earnings?

BioNTech SE has trailing twelve-month (TTM) revenue of $2.87B with profit margins of -39.60%. Earnings per share (EPS) is $-5.50.

Is BioNTech SE financially healthy?

BioNTech SE's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of 5.82 places it in the safe zone.

Is BNTX stock overvalued or undervalued?

Based on our DCF model, BioNTech SE's intrinsic value is $174.59, representing a margin of safety of 37.35%. The stock currently trades at a P/E of —x.

BNTX

BioNTech SE

NASDAQ: BNTX · HEALTHCARE · BIOTECHNOLOGY

$101.57

-0.48% today

Updated 2026-04-29

Market cap

$25.69B

P/E ratio

—

P/S ratio

8.95x

EPS (TTM)

$-5.50

Dividend yield

—

52W range

$80 – $124

Volume

1.2M

Market cap

$25.69B

P/E ratio

—

P/S ratio

8.95x

EPS (TTM)

$-5.50

Dividend yield

—

52W range

$80 – $124

Volume

1.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.0

Growth

7.3

Quality

B+

2.0

Profitability

8.3

Valuation

3/9

Piotroski F-Score

Weak

5.8

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$130.18

+28.17%

12-Month target

—

Intrinsic (DCF)

$174.59

Margin of safety

+37.35%

1 Strong Buy13 Buy5 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Altman Z 5.82 — safe zone

+ Free cash flow $237.67M — positive

+ 37.35% below intrinsic value

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at -39.60%

- Revenue declining -23.70% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM	2026 (E)
Revenue	$17.31B	$3.82B	$2.75B	$2.76B	$2.87B	$2.3B
Net income	$9.43B	$930.30M	$-665.30M	$-1.09B	$-302.14M	—
EPS	—	—	—	—	$-5.50	$-3.53
Free cash flow	$13.21B	$4.67B	$-244.60M	$269.81M	$237.67M	—
Profit margin	54.50%	24.36%	-24.18%	-39.59%	-39.60%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BNTX	$25.69B	32	2.0	2.0	8.3	7.3	+37.35%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

BioNTech SE trades at $101.57. Our Smart Value Score of 32/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 5.82, it sits in the safe zone. TTM revenue stands at $2.87B. with profit margins at -39.60%. Our DCF model estimates intrinsic value at $174.59.

Frequently asked questions

What is BioNTech SE's stock price?

BioNTech SE (BNTX) trades at $101.57.

Is BioNTech SE overvalued?

Smart Value Score 32/100 (Grade F, Strong Sell). DCF value $174.59.

What is the price target of BioNTech SE (BNTX)?

The analyst target price is $130.18, representing +28.2% upside from the current price of $101.57.

What is the intrinsic value of BioNTech SE (BNTX)?

Based on our DCF model, intrinsic value is $174.59, a +37.4% margin of safety versus $101.57.

What is the future stock price of BNTX by 2030?

Our research-backed model estimates BioNTech SE could reach $273.54 by 2030, based on analyst consensus, management guidance, and sector analysis.

What is BioNTech SE's revenue?

TTM revenue is $2.87B.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

5.82 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio8.95x

ROE-5.88%

Beta1.59

50D MA$98.00

200D MA$102.72

Shares out0.25B

Float0.10B

Short ratio—

Avg volume1.2M

Performance

1 week-3.69%

1 month+13.59%

3 months-10.71%

YTD+6.69%

1 year—

3 years—

5 years—

Compare

BNTX vs LLY →BNTX vs JNJ →BNTX vs ABBV →Stock screener →